CPhI Barcelona 2016News
This year’s CPHI held in Barcelona proved to be another busy and successful show for Rochem International. The Rochem team, led by CEO Robyn Frisch, and our EVP, Mr. Charles Dods met with a wide group of global and regional customers, manufacturers and suppliers.
Rochem also announced their strategic cooperation agreement with Shenzhen JY Med Technology Company for peptide products. This provides for Rochem to be JY Med’s exclusive distribution channel while advising them on all regulatory and compliance matters opening the door for JY Med to gain approval from regulatory authorities. JY Med’s expertise in the development of these specialized products, including the anti-diabetic and anti-obesity drug Liraglutide, is already gaining significant attention from leading generic customers.
“CPHI Worldwide is a key event in our calendar when we can bring together our manufacturing partners and customers in both the human and animal health fields” says Dods. “This has been another successful show for us as we continue to find solutions for our customers that will benefit all our stakeholders in the long term including patients, doctors and veterinarians”